News and resources for Canada's top financial advisors
Michal Marszal is a Portfolio Manager with Equities – Global Healthcare at CIBC Asset Management.
He is responsible for research coverage and stock selection within the global healthcare sector.
Prior to joining CIBC in 2017, Mr. Marszal was a consultant in healthcare equity research for Caisse de dépôt et placement du Québec. Previously, he was a senior analyst focusing on healthcare therapeutics at Lombard Odier Investment Managers. Mr. Marszal began his investment career as an analyst covering medical technology, and subsequently biotechnology companies at Sectoral Asset Management.
Mr. Marszal holds a Doctor of Medicine and Master of Surgery degree from McGill University. Upon graduating from medical school, he joined the Neurological Surgery Residency training program at Stanford University Medical Center as a resident physician. Mr. Marszal also holds an MBA degree in Finance from McGill University and a Bachelor of Arts degree in Molecular Biology from Bard College. He is a CFA charterholder and member of the CFA Society of Toronto.
Equities
Most of the sector maintains demand across economic cycles, PM says.
By Michal Marszal, CFA |October 2, 2023
6 min read
Certain segments expected to perform better than others this year.
By Michal Marszal, CFA |January 30, 2023
5 min read
Valuations are looking more attractive for those who can handle the risk.
By Michal Marszal, CFA |May 25, 2022
4 min read
Higher input costs are shrinking margins.
By Michal Marszal, CFA |May 18, 2022
Where the sector goes from here.
By Michal Marszal, CFA |January 24, 2022
3 min read
Pfizer and Moderna continue to come out on top.
By Michal Marszal, CFA |January 12, 2022
Understanding innovation in the sector helps reveal top stocks.
By Michal Marszal, CFA |May 31, 2021
Planning and Advice
May 8, 2024|5 min read
March 20, 2024|5 min read
May 7, 2024|4 min read
March 7, 2024|4 min read
February 15, 2024|3 min read
December 20, 2023|3 min read
Tax & Estate
January 17, 2024|4 min read
October 26, 2023|4 min read
We use cookies to make your website experience better. By accepting this notice and continuing to browse our website you confirm you accept our Terms of Use & Privacy Policy.